You are here

Drugmakers race to bring new cholesterol drugs to US market

New York

REGENERON Pharmaceuticals Inc and Sanofi may get a head start on their biggest competitor in bringing a new class of cholesterol drugs to the US market.

The US Food and Drug Administration (FDA) has until July 24 to make a decision on the companies' application to market

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom